Pulmotect Secures $1,751,430 Series A Financing Round

  • Feed Type
  • Date
    5/9/2016
  • Company Name
    Pulmotect
  • Mailing Address
    3900 Essex Ln. Houston, TX 77027 USA
  • Company Description
    Pulmotect, Inc. is a Houston-based biotechnology company, developing products that boost the innate immune system to protect against a wide range of lung infections. Our cofounders are leaders in the emerging science of innate immunity in the lungs.
  • Website
    http://www.pulmotect.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,751,430
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy